People with type 2 diabetes are very little aware of their cardiovascular risk and hardly talk about it with their doctor.
This is highlighted by the preliminary results presented by the International Diabetes Federation of the First Online World Survey aimed at people with type 2 diabetes to obtain relevant information about their knowledge of their cardiovascular risk.
The Taking Diabetes To Heart survey, carried out with the collaboration of Novo Nordisk, is available until March next year to favor the participation of people with type 2 diabetes.
Currently, diabetes affects 425 million adults in the world, and most cases are of type 2. Cardiovascular disease, which includes stroke, coronary heart disease and peripheral arterial disease, is the main cause of disability and death in death in deathPeople with type 2 diabetes.
To date, 943 responses have been received from the survey from 32 countries and the first results show that:
1 in 3 respondents living with type 2 diabetes considers that their cardiovascular risk is low.
26% of respondents did not know their cardiovascular risk or never received information about it after several years from the diagnosis of type 2 diabetes.
One in six respondents had never spoken with a healthcare professional about type 2 diabetes and the risks of developing some cardiovascular disease.
“The preliminary results of the Taking Diabetes to Heart surveThe two conditions, ”says Dr. Shaukat Sadikot, outgoing president of the International Diabetes Federation.
"There is an increase in the prevalence of type 2 diabetes, so it takes more than ever to better understand the link between these two conditions."
TAKING DIABETES TO HEART - www.idf.org/takingDiabetes2heart/survey - aimsto improve the health of the patient and the general population.
”Cardiovascular disease is the main cause of disability and death among people living with type 2 diabetes. Very few people with diabetes are being informed by doctors of their cardiovascular risk and the impact that this risk can have on their longevity and qualityof life, ”says Alan Moses, senior vice president and medical director of Novo Nordisk.
"So, we encourage people with diabetes to complete the Taking Diabetes to Heart survey since their results will give us relevant information that will serve as a basis for future actions that help improve their health."
The results of Taking Diabetes to Heart will serve to define the necessary actions to improve the health results of people with type 2 diabetes. The initiative will culminate in a full report that collects the specific results of each country and the necessary resources to help fosterKnowledge and awareness about cardiovascular risk among people with type 2 diabetes worldwide.
